KR880009652A - 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물 - Google Patents

3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물 Download PDF

Info

Publication number
KR880009652A
KR880009652A KR1019880001729A KR880001729A KR880009652A KR 880009652 A KR880009652 A KR 880009652A KR 1019880001729 A KR1019880001729 A KR 1019880001729A KR 880001729 A KR880001729 A KR 880001729A KR 880009652 A KR880009652 A KR 880009652A
Authority
KR
South Korea
Prior art keywords
dichloro
diamino
methylamino
benzoyl
pharmaceutically acceptable
Prior art date
Application number
KR1019880001729A
Other languages
English (en)
Inventor
에스 커어워어 슈레쉬
이이 슬로보우더 애덜프
Original Assignee
죤 제이 헤이간
아메리칸 사이아나밋드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죤 제이 헤이간, 아메리칸 사이아나밋드 캄파니 filed Critical 죤 제이 헤이간
Publication of KR880009652A publication Critical patent/KR880009652A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • C07D475/08—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H59/00—Control inputs to control units of change-speed-, or reversing-gearings for conveying rotary motion
    • F16H59/36—Inputs being a function of speed
    • F16H59/38—Inputs being a function of speed of gearing elements
    • F16H59/40—Output shaft speed
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H59/00—Control inputs to control units of change-speed-, or reversing-gearings for conveying rotary motion
    • F16H59/48—Inputs being a function of acceleration

Abstract

내용 없음.

Description

3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (6)

  1. 관절염 및 진행성 관절 열화의 치료에 있어 사용되는, 향상된 치료 계수를 가지며, 약제학적으로 허용가능한 담체와의 혼합물안에 유효량의 N-{3,5-디클로로-4-[(2,4-디아미노-6-프레리딜메틸)메틸아미노]벤조일}글루탐 산 또는 약제학적으로 허용가능한 그의 염을 갖는 것을 특징으로 하는 프테리딘 제약 조성물.
  2. 제1항에 있어서, 활성 성분이N-{3,5-디클로로-4-[(2,4-디아미노-6-프테리딜메틸)메틸아미노]벤조일}글루탐 산이고 조성물이 단위 복용 경구적 정제 형태로 있는 치료용 조성물.
  3. 유효량의N-{3,5-디클로로-4-[(2,4-디아미노-6-프테리딜메틸)메틸아미노]벤조일}글루탐 산 또는 그의 약제학적으로 허용 가능한 염을 투여하는 것을 특징으로 하는, 관절염 및 진행성 관절 열화의 치료방법.
  4. 제3항에 있어서, 치료 계수가 칼슘 로이코보린의 후 투여에 의해 본질적으로 증가되는 방법.
  5. 제4항에 있어서, 보조약 관절염을 3,5-디클로로메토트렉세이트로 치료하고, 치료 계수가 약 6인 방법.
  6. 제3항에 있어서, 활성 성분이 3,5-디클로로메토트렉세이트이고 바람직한 복용 요법이 하루당 1-3mg/체중 kg 인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880001729A 1987-02-20 1988-02-19 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물 KR880009652A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/017,286 1987-02-20
US07/017,286 US4746662A (en) 1987-02-20 1987-02-20 Treatment of arthritis with 3,5-dichloromethotrexate

Publications (1)

Publication Number Publication Date
KR880009652A true KR880009652A (ko) 1988-10-04

Family

ID=21781766

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880001729A KR880009652A (ko) 1987-02-20 1988-02-19 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물

Country Status (5)

Country Link
US (1) US4746662A (ko)
EP (1) EP0282690A3 (ko)
JP (1) JPS63208521A (ko)
KR (1) KR880009652A (ko)
AU (1) AU1197388A (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2090075T3 (es) * 1989-12-11 1996-10-16 American Cyanamid Co Procedimiento para la preparacion de diastereoisomeros opticamente puros de compuestos de tetrahidrofolato.
US5030634A (en) * 1990-03-29 1991-07-09 Krumdieck Carlos L 10-deazaaminopterin: a new arthritis remittive drug
US20100061984A1 (en) * 2006-01-20 2010-03-11 The Trustees Of The University Of Pennsylvania Compositions and methods for modulation of suppressor t cell activation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4426384A (en) * 1982-08-05 1984-01-17 John R. A. Simoons Treatment of rheumatoid arthritis and related diseases

Also Published As

Publication number Publication date
EP0282690A2 (en) 1988-09-21
EP0282690A3 (en) 1990-01-10
AU1197388A (en) 1988-08-25
JPS63208521A (ja) 1988-08-30
US4746662A (en) 1988-05-24

Similar Documents

Publication Publication Date Title
ATE71293T1 (de) Arzneiformulierung.
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
FI920026A0 (fi) Farmaceutisk komposition anvaendbar som avmagringsmedicin.
KR930007441A (ko) 의약품
KR910019618A (ko) 발기부전증 치료용 제약 조성물
KR850700109A (ko) 항 이뇨제 ddavp 및 그의 제조 방법
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
RU95101385A (ru) Продукты, содержащие g-csf и tnf связующие протеина
DE68926115D1 (de) Verfahren zur behandlung von akne
KR880009652A (ko) 3-5-디클로로메토트랙세이트를 사용하는 류마티스성 관절염 치료법 및 그에 유용한 조성물
DE3875611T2 (de) Pharmazeutische zusammensetzungen.
JPS5781409A (en) External plaster
SE8701077D0 (sv) Pharmaceutical composition
KR890007728A (ko) 진통제 제조방법
MX9800809A (es) Procedimiento para preparar formas de dosis solidas de dosis muy bajas del farmaco.
KR830008678A (ko) 진통 조성물
KR880002521A (ko) 약제 제형
KR900017599A (ko) 종양 치료용 약학 조성물
KR890007737A (ko) 진토작용을 하는 약제
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
KR890001558A (ko) 공황(恐慌) 장애를 경감시키는 제피론 및 이의 약학적 허용 산부가염
KR890001567A (ko) 디플루니살 및 트로메타민-함유 조성물
KR890000472A (ko) 화합물
SE8304818L (sv) Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan

Legal Events

Date Code Title Description
WITB Written withdrawal of application